DelfaGLP-1 Atlas

← Trials/Trial dossier/NCT06003985

Completed

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Assessment of Preoperative Gastric Content With Ultrasound in Patients Taking GLP1 Agonists

Asset

GLP-1 / incretin class catch-all

Listed sites

8

Recruiting sites

—

Enrollment

354

actual

Study population

Perioperative / gastric aspiration risk

Key I/E criterion

—

Primary endpoint

•Delayed gastric emptying

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT06003985
Org study ID2023-0867

Timeline

Milestones

Study first posted2023-08-22actual
Study start2023-08-29actual
Primary completion2025-01-31actual
Study completion2025-02-01actual
Last update posted2025-11-26actual

Assets

Investigational agents

GLP-1 / incretin class catch-all

Study populations

Who this study enrolls

Perioperative / gastric aspiration risk

Eligibility

Who can enroll

Minimum age18 Years
Maximum age99 Years
SexAll
Healthy volunteersNot accepted
Sampling methodNon probability sample

Study population text

The study population will be comprised of patients scheduled for surgery at HSS who meet the following inclusion criteria and none of the exclusion criteria.

Inclusion criteria

•GLP 1 patient group: any patient on GLP1 agonists that are dosed once per week (semaglutide, dulaglutide, tirzepatide), for all indications.
•Control group (No GLP 1 patients): any patient not on GLP1 agonists that are dosed once per week, for all indications.

Exclusion criteria

•patient refusal to participate
•patients with gastric bypass or any other gastric surgery
•large hiatal hernia
•patients with large ascites
•patients on peritoneal dialysis
•emergency surgery
•pre-existing diagnosis of gastroparesis

Endpoints (3)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Other clinical outcomes

3 endpoints
Primary/protocol endpoint

incidence of delayed gastric emptying

Time frame:This will be measured pre-operatively in the holding room area.

categorical status, event

Secondary/protocol endpoint

Nothing by mouth (NPO) intervals

Time frame:This will be measured pre-operatively in the holding room area.

descriptive

Secondary/protocol endpoint

Presence of gastric peristalsis

Time frame:This will be measured pre-operatively in the holding room area.

categorical status, descriptive

Publications (3)

Bibliography

Records linked to this trial through ClinicalTrials.gov references, PubMed NCT search, and curated study seeds. 'Canonical' marks design/result papers; others are registry references or candidates.

Registry references + supporting bibliography

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 1, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.